NSEMonitoring Agency Report6d ago · 14 Aug 2026, 03:33 pm
Monitoring Agency Report
TIL Limited · TIL
✦ AI SummaryResults
TIL Limited has issued a monitoring agency report for the quarter ended June 30, 2026, related to the Rights Issue of equity shares. The report is in line with the format prescribed by SEBI, capturing comments where applicable. The issuer's management/audit committee of the board of directors will review certain sections of the report before dissemination through stock exchanges.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Monitoring Agency Report for the quarter ended 30 June, 2026
Attachments (1)
📄pdf
Download →
TIL_14082026153215_ReportoftheMonitoringAgengyJUNE.pdf
View document text
14th August, 2025
The Manager, The Secretary,
Listing Department Listing Department
National Stock Exchange of India BSE Ltd.,
Ltd., P.J. Towers,
Exchange Plaza, C-1, Block – G, Dalal Street, Fort,
Bandra Kurla Complex, Bandra (E), Mumbai 400001.
Mumbai 400 051
Scrip Code: 505196
Stock Code: TIL
Dear Sir / Madam,
Sub: Report of the Monitoring Agency pursuant to Regulation 32 of SEBI LODR
relating to the Rights Issue of equity shares of TIL Limited
Pursuant to Regulation 32 of SEBI LODR, please find enclosed herewith the Report
dated 14th August, 2026 of CARE Ratings Limited, the Monitoring Agency appointed
by the Company to monitor the utilization of the proceeds, during the quarter ended
30th June, 2026, from the issue of 1,20,91,760 partly paid up Equity Shares.
A copy of the said report is also available on the website of the Company at
www.tilindia.in.
Request you to please take the same on record.
Thanking you,
Yours faithfully,
Encl: As above
No. CARE/KRO/GEN/2026-27/1070
The Board of Directors
TIL Limited
1, Taratolla Road, Garden Reach
Kolkata - 700024
West Bengal
August 14, 2026
Dear Sir/Ma’am,
Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Rights Issue of TIL Limited (“the
Company”)
We write in our capacity of Monitoring Agency for the Rights Issue for the amount aggregating to Rs. 199.51 crore of the
Company and refer to our duties cast under 82 of the Securities & Exchange Board of India (Issue of Capital & Disclosure
Requirements) Regulations.
In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid SEBI
Regulations and Monitoring Agency Agreement dated February 23, 2026.
Request you to kindly take the same on records.
Thanking you,
Yours faithfully,
Shivangi Sharma
Assistant Director
Shivangi.sharma@careedge.in
CARE Ratings Limited
Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital
15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East),
Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022
Phone: +91-22-6754 3456 • www.careedge.in
CIN-L67190MH1993PLC071691
Report of the Monitoring Agency
Name of the issuer: TIL Limited
For quarter ended: June 30, 2026
Name of the Monitoring Agency: CARE Ratings Limited
(a) Deviation from the objects: No
(b) Range of Deviation: Nil
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of
the issue based on the information provided by the Issuer and information obtained from sources believed by it to be
accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/
certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA
which accepts no responsibility whatsoever for loss or damage from the use of the said information. The views and
opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner
whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship
between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not
act as an expert as defined under Section 2(38) of the Companies Act, 2013.
The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report
pertains and may receive separate compensation for its ratings and certain credit-related analyses. We confirm that
there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue
proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity.
We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments where
applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be
captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting
their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been
reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board.
Signature:
Name and designation of the Authorized Signatory: Shivangi Sharma
Designation of Authorized person/Signing Authority: Assistant Director
CARE Ratings Limited
Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital
15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East),
Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022
Phone: +91-22-6754 3456 • www.careedge.in
CIN-L67190MH1993PLC071691
1) Issuer Details:
Name of the issuer : TIL Limited
Name of the promoter : M/s TIL Global Private Limited
Industry/sector to which it belongs : Industrial Products
2) Issue Details
Issue Period : March 30, 2026, to April 08, 2026
Type of issue (public/rights) : Rights Issue (RI)
Type of specified securities : Equity shares
IPO Grading, if any : Not applicable
Issue size (in crore) : Rs. 199.51 crore
3) Details of the arrangement made to ensure the monitoring of issue proceeds:
Source of information / certifications Comments of the
Comments of the
Particulars Reply considered by Monitoring Agency for Board of
Monitoring Agency
preparation of report Directors
Out of the total Rights Issue of Rs. 199.51 crore, the company
has raised Rs. 149.64 crore through application money in
CA certificate*,
April 2026. The utilization of proceeds from the Rights issue
Bank statements,
(Application money) is in line with the offer document and
No-dues certificate from lenders,
Board Resolution dated April 28, 2026.
Confirmation from lenders against payment
Whether all utilization is as per the
Yes received towards payment of unsecured loans, Noted
disclosures in the Offer Document? The company has utilized Rs 37.50 crore towards the object
Management certificate,
“General Corporate Purposes”, Rs 2.68 Cr towards “Issue
Offer document,
expenses” and balance of Rs 109.46 Cr towards
Board Resolution (BR) and
“Repayment/pre-payment, in full or in part, of certain
Declaration from CFO and Director- Finance
outstanding borrowings availed by the Company, including
the interest “.
CA certificate*, In the offer document, the utilization of proceeds from
Whether shareholder approval has been Bank statements, Rights issue (application money) was as follows:
obtained in case of material deviations# Not No-due certificate/confirmation from lenders,
Noted
from expenditures disclosed in the Offer applicable Confirmation from lenders against payment • Repayment/pre-payment, in full or in part, of certain
Document? received towards payment of unsecured loans, outstanding borrowings including the interest- Rs. 110
Management certificate, crores.
Source of information / certifications Comments of the
Comments of the
Particulars Reply considered by Monitoring Agency for Board of
Monitoring Agency
preparation of report Directors
Offer document, • General Corporate Purposes (GCP)- Rs. 26.74 crore
Board Resolution and • Issue Expenses- Not specified in the offer document
Declaration from CFO and Director- Finance
However, as per offer document, the Board or the Rights
Issue Committee were given the rights to change the
schedule of implementation and deployment of Net
Proceeds, including the manner, method, and timing of
deployment (whether by preponing or deferring such
utilization in part or full) of the Net Proceeds, in case of any
delay in payment and/or non-receipt of Call Monies and/or
in case of any change in our business requirements and other
commercial considerations, subject to compliance with
applicable laws.
Therefore, the Board in accordance with BR
[Showing first 8,000 characters — download PDF for full document]